NAD+ Dosage & Protocol Guide: Injections, IV Therapy, and Reconstitution Explained
NAD+ (Nicotinamide Adenine Dinucleotide)
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme the body uses for cellular energy production, DNA repair, and normal metabolic function. NAD+ levels and metabolism change with age, which is why NAD+ and its precursors are widely studied in aging, metabolism, and cellular health research.
How NAD+ Works
Cellular Energy ↑ → Mitochondrial Function ↑ → DNA Repair ↑ → Cellular Resilience ↑
NAD+ plays a central role in ATP production and helps support pathways involved in cellular repair and longevity, including sirtuins. Supporting NAD+ levels may improve energy, recovery, mitochondrial efficiency, and metabolic function.
NAD+ Research Frame-work Subcutaneous Protocol
Research context:
Subcutaneous NAD+ dosing is commonly discussed in wellness and research communities, but a standardized clinical SubQ dosing protocol has not been established. The 50–100 mg progression below reflects a practical community-style framework rather than an FDA-approved treatment schedule.
Subcutaneous NAD+ dosing is commonly discussed in wellness and research communities, but a standardized clinical SubQ dosing protocol has not been established. The 50–100 mg progression below reflects a practical community-style framework rather than an FDA-approved treatment schedule.
500 mg vial + 3.0 mL BAC Water → 1 unit = 1.67 mg → Daily or Pulse-Based NAD+ Support
SubQ Setup
Vial500 mg
Water3.0 mL bacteriostatic water
Concentration166.7 mg/mL
Conversion1 unit = 1.67 mg
Week 1
Loading
Dose50 mg
Units30 units
Volume0.30 mL
Week 2
Build
Dose75 mg
Units45 units
Volume0.45 mL
Weeks 3–16
Maintenance
Dose100 mg
Units60 units
Volume0.60 mL
Why use this version?
Practical Home Use
Subcutaneous NAD+ is the most practical home-use approach for consistent support. It gives a steadier structure than IV use and is easier to maintain during longer support phases.
Support Style
This is usually the easiest format for building a repeatable routine for energy, recovery, metabolic support, and broader cellular support phases.
Other NAD+ Delivery Approaches
Other Delivery Approaches
IV Infusion
Most directly studied injectable route in humans
IM Injection
Used in wellness settings; limited clinical evidence
SubQ Injection
Common in community use; limited clinical evidence
How to Use NAD+ (Cycle, Timing & Injection)
Research Typical FrequencyOnce daily or pulse-based
Research Typical Cycle Length8–16 weeks
Research Best TimeMorning
Research Injection TypeSubcutaneous
Research Frame-work Best Time to Take
Morning is usually preferred because NAD+ is more commonly used for energy, cellular support, and metabolic function rather than sleep support.
Some people still use it at other times, but morning usually fits best with the intended effect profile.
Staying hydrated before and after dosing often improves comfort.
Where to Inject
Abdomen, thigh, or upper arm are the most common subcutaneous sites.
Alternate sites regularly to reduce irritation.
Use a consistent routine if running longer support phases.
When to Use
During recovery phases
During higher metabolic demand or stress-support phases
As part of a broader mitochondrial or longevity-focused stack
When energy support, cellular repair support, or recovery support is the main goal
Simple Strategy
Think in Support Phases
Instead of thinking “I need NAD+ all the time,” it usually works better to think: “When does my system need extra support?”
Best Practical Use
NAD+ usually works best when tied to a purpose — recovery, stress, mitochondrial demand, or a broader stack phase — rather than being treated like a permanent daily stim.
Why reassess?
NAD+ does not have a clinically established “on/off” cycle. Shorter phases and pulse-style use are commonly discussed in wellness and research communities because they make it easier to judge whether the added NAD+ is actually helping with the intended goal.
NAD+ does not have a clinically established “on/off” cycle. Shorter phases and pulse-style use are commonly discussed in wellness and research communities because they make it easier to judge whether the added NAD+ is actually helping with the intended goal.
Why the Route Matters
IV
Delivers NAD+ directly into the bloodstream.
This is the injectable route with the most direct human research.
Infusion speed matters because faster IV NAD+ can be difficult to tolerate.
IM
Places NAD+ into muscle, where it is absorbed into circulation.
IM use is common in some wellness settings, but human dose-comparison data remain limited.
SubQ
Places NAD+ into the tissue under the skin for slower absorption.
SubQ use is popular because it is practical for repeated dosing, but standardized human pharmacokinetic data are limited.
Simple takeaway:
The routes deliver NAD+ differently, but there is not enough human research to say exactly how much more or less effective one route is compared with another. Most route-specific dose ranges come from clinical-wellness and community practice rather than head-to-head trials.
The routes deliver NAD+ differently, but there is not enough human research to say exactly how much more or less effective one route is compared with another. Most route-specific dose ranges come from clinical-wellness and community practice rather than head-to-head trials.
Reconstitution & Dosing (500 mg Vial)
Reconstitution & Dosing
Vial500 mg
Water3.0 mL bacteriostatic
Concentration166.7 mg/mL
Conversion1 unit = 1.67 mg
Dose Reference
30 units = 50 mg
45 units = 75 mg
60 units = 100 mg
90 units = 150 mg
Reconstitution Steps
Draw 3.0 mL bacteriostatic water
Inject slowly down the vial wall
Gently swirl, do not shake
Refrigerate immediately after reconstitution
Handling Note
Protect from light and avoid freeze-thaw cycles once reconstituted.
Storage & Shelf Life
Storage & Shelf Life
Lyophilized (unmixed)
Refrigerated (2–8°C): ~1–2 years
Frozen (−20°C): ~2+ years
Keep sealed, dry, and protected from light
Avoid repeated freeze-thaw cycles
Reconstituted (mixed)
Reconstituted: 2–8°C (36–46°F)
Best used within 14 days
Protect from light
Avoid freeze-thaw cycles
Use the product-specific beyond-use date when available.
There is not one universal evidence-based shelf life for every reconstituted NAD+ formulation.
Why the use window is shorter
NAD+ is often treated a little more cautiously after reconstitution than many peptides, especially when people want to prioritize potency and stability. This is why shorter use windows are commonly preferred.
NAD+ is often treated a little more cautiously after reconstitution than many peptides, especially when people want to prioritize potency and stability. This is why shorter use windows are commonly preferred.
Best practice:
NAD+ stability depends on the formulation, sterility, preservatives, storage temperature, and handling. Product-specific guidance is more reliable than applying one generic use window to every vial.
NAD+ stability depends on the formulation, sterility, preservatives, storage temperature, and handling. Product-specific guidance is more reliable than applying one generic use window to every vial.
Research Time Between Cycles
Support Phase → Reset Phase → Support Phase Again
Simple + Practical Guideline
Cycle Length4–8 weeks
Time Off2–4 weeks
Why not run it nonstop?
NAD+ is not a stimulant. It is a cellular cofactor.
The body naturally regulates NAD+ levels and adjusts enzyme activity like sirtuins and PARPs. If you run it continuously, you may notice diminishing returns as the system adapts to higher availability.
NAD+ is not a stimulant. It is a cellular cofactor.
The body naturally regulates NAD+ levels and adjusts enzyme activity like sirtuins and PARPs. If you run it continuously, you may notice diminishing returns as the system adapts to higher availability.
Best Ways to Structure It
Option 14–8 weeks on, 2–4 weeks off
Clean reset and usually the easiest structure to follow
Option 21–3x weekly pulse use
No strict cycle, less adaptation, often feels better long-term
Option 3Stack-based use
Use NAD+ during higher-demand phases, then reset once that phase ends
When to Take Time Off Sooner
No added benefit anymore
Feeling flat or unchanged
Overuse fatigue, which is uncommon but can happen
Common Mistakes
Running high NAD+ daily for months
Treating it like caffeine
Not pairing it with a purpose such as recovery, stress support, or a stack phase
Simple content version:
NAD+ is best used in cycles or pulses, not continuously. Most people run it for 4–8 weeks, then take 2–4 weeks off to maintain effectiveness and allow the body to reset.
NAD+ is best used in cycles or pulses, not continuously. Most people run it for 4–8 weeks, then take 2–4 weeks off to maintain effectiveness and allow the body to reset.
What Human Research Has Studied
IV NAD+ Research
Direct IV NAD+ has been studied in humans, but the evidence base is still small.
A pilot study tracked NAD+ and its breakdown products during a six-hour IV infusion.
A newer 2026 real-world study used 500 mg IV NAD+ daily for four consecutive days.
During the 2026 study, nausea and other GI symptoms, increased heart rate, and chest pressure were commonly reported during NAD+ infusion.
Symptoms resolved when the infusions ended, but the study did not establish long-term effectiveness.
Bottom line:
Human research confirms that IV NAD+ can be administered and studied, but we still do not have strong clinical evidence proving that injected NAD+ improves energy, longevity, recovery, or metabolic health in otherwise healthy people.
Human research confirms that IV NAD+ can be administered and studied, but we still do not have strong clinical evidence proving that injected NAD+ improves energy, longevity, recovery, or metabolic health in otherwise healthy people.
Biological Role & Research Interests
Essential for normal cellular energy production
Required for enzymes involved in DNA repair
Plays an important role in mitochondrial and metabolic function
Closely connected with sirtuin and cellular-stress pathways
Being studied for aging, metabolic health, recovery, and cellular resilience
Clinical benefits from injected NAD+ are still being investigated
Potential Side Effects
Nausea or gastrointestinal discomfort
Flushing or warmth
Injection-site irritation with IM or SubQ use
Chest pressure or increased heart rate can occur during IV infusion
IV NAD+ may need to be infused slowly for better tolerability
Long-term safety and effectiveness data remain limited
Stacking Strategies
NAD+ → Cellular Energy ↑ → Mitochondrial Demand ↑ → Stack Support Amplifies Effects
Energy Stack: NAD+ + MOTS-c
Longevity Stack: NAD+ + Epitalon
Mitochondrial Support: NAD+ + SS-31
Research note:
These combinations are discussed because they involve complementary cellular-energy or mitochondrial pathways, but controlled human trials have not established these combinations as validated treatment protocols.
These combinations are discussed because they involve complementary cellular-energy or mitochondrial pathways, but controlled human trials have not established these combinations as validated treatment protocols.
Important Notes
NAD+ is a coenzyme, not a peptide.
IV NAD+ has limited but real human research; SubQ and IM protocols rely much more heavily on wellness and community use.
There is no standardized FDA-approved NAD+ injection protocol for energy, anti-aging, recovery, or longevity.
IV NAD+ can cause significant temporary discomfort if infused too quickly.
Community dosing and cycling frameworks should not be confused with proven clinical treatment schedules.
NAD+ is currently listed by FDA among bulk substances nominated for evaluation for use in 503A compounding; nomination does not mean FDA approval of NAD+ injections for wellness use.
Important Disclaimer
NAD+ is a naturally occurring coenzyme, but injectable NAD+ protocols for energy, recovery, anti-aging, and longevity are not FDA-approved treatment regimens. IV NAD+ has limited human research, while SubQ and IM dosing rely largely on wellness and community practice. This content is for educational purposes only.
Research & References
Primary Research
- Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism. 2018.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism. 2018.
- Cantó C, Menzies KJ, Auwerx J. NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act Between Mitochondria and the Nucleus. Cell Metabolism. 2015.
- Imai SI, Guarente L. NAD+ and Sirtuins in Aging and Disease. Trends in Cell Biology. 2014.
- Verdin E. NAD+ in Aging, Metabolism, and Neurodegeneration. Science. 2015.
Research Note: Most clinical research evaluates strategies that raise NAD+ levels indirectly (such as nicotinamide riboside or nicotinamide mononucleotide) rather than direct NAD+ administration; dosing protocols for intravenous, intramuscular, or subcutaneous NAD+ are based on clinic and provider practice rather than standardized clinical trials.
Comments
Post a Comment